UB Paderborn / Katalog / Suche / in CDI

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

The lancet oncology, 2014-04, Vol.15 (4), p.415-423

2014

Volltextzugriff (PDF)

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial

Journal of clinical oncology, 2016-01, Vol.34 (3), p.244-250

2016

Volltextzugriff (PDF)

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas

Journal of clinical oncology, 2015-12, Vol.33 (36), p.4276-4283

2015

Volltextzugriff (PDF)

Cohort Study Based on the Seventh Edition of the TNM Classification for Gastric Cancer: Proposal of a New Staging System

Journal of clinical oncology, 2011-06, Vol.29 (17), p.2364-2371

2011

Volltextzugriff (PDF)

Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2863-2873

2009

Volltextzugriff (PDF)

Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer

Clinical & experimental metastasis, 2010-03, Vol.27 (3), p.141-149

2010

Volltextzugriff (PDF)

Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

Journal of clinical oncology, 2002-04, Vol.20 (7), p.1864-1873

2002

Volltextzugriff (PDF)

One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial

JAMA : the journal of the American Medical Association, 2012-03, Vol.307 (12), p.1265

2012

Volltextzugriff (PDF)

Phase I/II Study of Sequential Dose-Intensified Ifosfamide, Cisplatin, and Etoposide Plus Paclitaxel As Induction Chemotherapy for Poor Prognosis Germ Cell Tumors by the German Testicular Cancer Study Group

Journal of clinical oncology, 2007-12, Vol.25 (36), p.5742-5747

2007

Volltextzugriff (PDF)

Histopathological and molecular features of late relapses in non‐seminomas

BJU international, 2011-03, Vol.107 (6), p.936-943

2011

Volltextzugriff (PDF)

Sequential Versus Single High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: Long-Term Results of a Prospective Randomized Trial

Journal of clinical oncology, 2012-03, Vol.30 (8), p.800-805

2012

Volltextzugriff (PDF)

Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors

European urology, 2011-10, Vol.60 (4), p.850-855

2011

Volltextzugriff (PDF)

The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)

European journal of cancer (1990), 2013-03, Vol.49 (4), p.835-842

2013

Volltextzugriff (PDF)

Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1641-1648

2001

Volltextzugriff (PDF)

Vorinostat in refractory soft tissue sarcomas – Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)

European journal of cancer (1990), 2016-09, Vol.64, p.74-82

2016

Volltextzugriff (PDF)

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

Cancer, 2014-08, Vol.120 (15), p.2325-2333

2014

Volltextzugriff (PDF)

Camptothecin and podophyllotoxin derivatives : Inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile

Drug safety, 2006-01, Vol.29 (3), p.209-230

2006

Volltextzugriff (PDF)

External Validation of the Proposed Kiel Staging System and Comparison with the Old (6th Edition) and the Currently Used (7th Edition) TNM Classification in Gastric Cancer

Oncology research and treatment, 2018-01, Vol.41 (3), p.122-128

2018

Volltextzugriff (PDF)

Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer

The Prostate, 2008-01, Vol.68 (1), p.72-77

2008

Volltextzugriff (PDF)

Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines

Anti-cancer drugs, 2007-03, Vol.18 (3), p.245-254

Hartmann, Jörg T

2007

Volltextzugriff (PDF)

Patterns of Relapse after Chemotherapy in Patients with High-Risk Non-Seminomatous Germ Cell Tumor

Oncology, 2010-01, Vol.78 (1), p.47-53

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

Cohort Study Based on the Seventh Edition of the TNM Classification for Gastric Cancer: Proposal of a New Staging System

Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer

Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial

Phase I/II Study of Sequential Dose-Intensified Ifosfamide, Cisplatin, and Etoposide Plus Paclitaxel As Induction Chemotherapy for Poor Prognosis Germ Cell Tumors by the German Testicular Cancer Study Group

Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial

Histopathological and molecular features of late relapses in non‐seminomas

Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial

Sequential Versus Single High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: Long-Term Results of a Prospective Randomized Trial

Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors

The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)

Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis

Vorinostat in refractory soft tissue sarcomas – Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib

Camptothecin and podophyllotoxin derivatives : Inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profile

External Validation of the Proposed Kiel Staging System and Comparison with the Old (6th Edition) and the Currently Used (7th Edition) TNM Classification in Gastric Cancer

Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer

Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines

Patterns of Relapse after Chemotherapy in Patients with High-Risk Non-Seminomatous Germ Cell Tumor

Suchergebnisse filtern